Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Maxxeus is a prominent provider of innovative allograft tissue solutions, specializing in dental, orthopedic, and wound care applications. Operating as a brand of Community Tissue Services (CTS), one of the largest non-profit tissue banks in the United States, Maxxeus offers an extensive portfolio of regenerative biologics. Their product line includes bone grafting materials, barrier membranes, and soft tissue substitutes designed to enhance clinical outcomes in reconstructive surgeries. The company is recognized for its rigorous safety standards and state-of-the-art processing facilities, which are accredited by the American Association of Tissue Banks (AATB). Maxxeus serves a global market, providing surgeons and clinicians with high-quality, sterile grafts for diverse regenerative procedures.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Maxxeus.